EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C20H17N3O2 |
| Net Charge | 0 |
| Average Mass | 331.375 |
| Monoisotopic Mass | 331.13208 |
| SMILES | O=C1c2cccc(O)c2N[C@@H](c2cnc3ccccc23)[C@@H]2CC=CN12 |
| InChI | InChI=1S/C20H17N3O2/c24-17-9-3-6-13-19(17)22-18(16-8-4-10-23(16)20(13)25)14-11-21-15-7-2-1-5-12(14)15/h1-7,9-11,16,18,21-22,24H,8H2/t16-,18-/m0/s1 |
| InChIKey | LPMXORSOJRRADU-WMZOPIPTSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Xenorhabdus eapokensis (ncbitaxon:1873482) | - | PubMed (29596433) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Dehydro tilivalline (CHEBI:219990) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (6S,6aS)-4-hydroxy-6-(1H-indol-3-yl)-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one |
| Manual Xrefs | Databases |
|---|---|
| 78442857 | ChemSpider |